Management of Prostatomegaly (Izam-I-Ghudda-I-Mazi) in Unani System of Medicine: An Overview

Authors: Quraishi HA*, Arsheed Iqbal, Shabir Ahmad Bhat, Naquibul Islam, Qamar Alam Khan

Journal: Open Access Journal of Urology & Nephrology. Article type: Review Article. Published: 2019-10-18. DOI: https://doi.org/10.23880/oajun-16000167

Abstract

Prostatomegaly is the enlargement of prostate gland in elderly males which results urinary symptoms in them. The prevalence of prostatomegaly is age dependent with the initial development usually after 40 years reaching approximately 90 percent after 70 years of age. Since prostatomegaly itself is not a fatal disease but its most important outcome is urinary flow obstruction, which is miserable for the patient and affects physical activities and mental health of the person. The symptoms of prostatomegaly include hesitancy, increased frequency of micturition, dribbling, narrow stream, nocturia, retention of urine, urgency, incontinence etc. Great Unani physician have been managing depending upon the age and nature of the symptoms. The great ancient scholars have also managed this ailment by different regimental therapies, pharmacotherapy and dietotherapy.

Keywords: Prostatomegaly, Warm-e-Ghudda-e-Mazi, Micturition, Unani Medicine

Islam4 and Qamar Alam Khan5

[email protected] regimental therapies, pharmacotherapy and dietotherapy.

**Keywords:** Prostatomegaly; _Warm-e-Ghudda-e-Mazi_; Micturition; Unani Medicine Management of Prostatomegaly (_Izam-I-Ghudda-I-Mazi_) in Unani System of Medicine: An Overview

Introduction

In classical literature of _Unani_ System of Medicine prostatomegaly has been mention as _Izam-i-Ghudda-i-_ _Mazi Sada, Sala`a Ghudda-e-Mazi, Warm-e-Ghudda-e-Mazi,_ _and Warm-e-Unq-e-Masanah_ [1-3]. It is a condition J Urol Nephrol

resembling the clinical feature discussed under *Usr-i-Bawl* (Dysuria), *Ihtibas-i-Bawl* (Retention of Urine) and *Taqtir-i-Bawl* (Dribbling of Urine), narrow stream, urgency, incontinence etc. in classical literature of USM. Unani Physicians have mentioned that *Warm-i-Aza-i-Mujawira* (Inflammation/swelling of neighboring organs) of urethra may compress it causing obstruction to flow urine [4,5]. These conditions may be correlated to Benign Prostatic Hyperplasia (BPH) where enlarged prostate compresses prostatic urethra and produces symptoms such as hesitancy, intermittent voiding, diminished stream, incomplete emptying, and post void leakage.

It is caused by the abnormal accumulation of *Balgham Ghaliz* or *Mawad-e-Ghaliz* (Thick phlegm) which has been mentioned as the leading cause of swelling (*Auram*) / inflammation of any *Azw Ghudadi* (Gland) of the body [6]. It is characterized by urinary frequency, hesitancy, strangury and urgency with weak urinary stream. Patient may have feeling of incomplete bladder emptying, straining and terminal dribbling. Acute and chronic urinary retention may also be present. *Unani* physicians are treating the symptoms of BPH for centuries with safe *Unani* herbal remedies.

**Review of Literature**

Cause of Prostatomegaly is not much exactly understood but it is now clear that androgens have central role in its development [7]. In Unani system of medicine Prostatomegaly has been described under the headings of *Sala’a* *Ghudda-e-Mazi*, *Warm-e-Ghudda-e-Mazi*, and *Warm-e-Unq-e-Masanah*. However mostly in our classical texts symptomatic treatment of Prostatomegaly can be found under different headings like *Ehtabass-e-Baul*, *Taqteurul Baul*, *Usr-e-Baul* etc [8]. Father of medicine Hippocrates (*Buqrat*) described *Auram* (swellings) because of abnormality in four humors (*Akhlate arba*), a soft swelling is due to (Khilt-e-Balgham), a hard swelling (*Warm-e-Salb*) or *Sala’a* due to black humour *Khilt-e-Sauda* and third type is combination of the two (*Balgham and Sauda*). Attiba have categorized *Sala’a* (tumor) under the heading of *Warm* (an abnormal growth or swelling) [9]. Maseehi described *Sala’a* as a swelling or over growth due to Balgham or *Mawad-e-Galeez* [10].

The paradigm for the management of Prostatomegaly has shifted from being purely surgical to a combination of medical and surgical management in past two decades. Though trans-urethral resection of prostate (TURP) remains the gold standard in Prostatomegaly management, new clinical research has opened up avenues of medical management. Medical management is effective in reducing the symptoms and prostate size, but allopathic medicine do have various side effects like erectile dysfunction, loss of libido, impotency, vertigo, cardiovascular disorders etc [11,12]. *Unani* physicians are treating the symptoms of Prostatomegaly by different Unani formulation and regimen.

**Incidence**

Benign prostatic hyperplasia (BPH) prevalence in Ghana is responsible for 60% acute retention of urine and 28.6% of haematuria. Worldwide prevalence of BPH varies from 20-62% in men over 50 years and this includes USA, UK, Japan and Ghana. BPH co-existing with PC – Reports from USA, UK and Japan and Ghana reveal moderate association of BPH and PC is 3-20%.

Prostate Cancer prevalence – There is high prevalence in USA, Scandinavian Countries, African Americans (AA) and Caribbean blacks. Ghana, Trinidad & Tobago have reported high prevalence of 6–10% in men aged 50 years and above. Overall PC causes 18% of disorders of the prostate gland. The worldwide incidence in men over 50 years is 11.7% that is 15th commonest of new cancers worldwide, 19% of new cancers in developed countries and 5% in developing countries [13]. The prevalence per population is lowest in Asia/China 1.9% or 10/100,000 in Caucasian Americans 1.4-2.4% or 104/100,000, African Americans 2.2-5.1% or 272/100,000, in Caribbean Men about 5-10% and we have established in Ghanaian Men from 6.3%-7% which is on the high side [14,15].

Management of Prostatomegaly by different Unani formulation and regimental therapies.

- *Ilaj-Bil-Ghiza* (Dietotherapy)

- *Ilaj-Bil-Dawa* (Pharmacotherapy)

- *Ilaj-Bil-Tadbeer* (Regimenal therapy)

- *Ilaj-Bil-Yad* (Surgery)

*Usul-i-Ilaj* (Principles of Treatment)

- *Tanqiya* (Evacuation of Morbid matter i.e. *Mawad-e-Ghaliz*).

- *Talyin-o-Irkha-o-Tahlil-i-Waram* (To soften, relax and resolve the swelling / *Auram*).

- *Ikhraj-i-Bawl* *Bazari-a-Qasatir* (Urethral catheterization) in acute retention.

*Ilaj-Bil-Dawa* (Pharmacotherapy)

- Oral Administration of *Maul-Usul* with castor oil.

- Oral Administration of *Joshanda* (decoction) of following drugs (Table 1) along with Gulqand in the morning [16].

Table 1: Ingredients of _Joshanda_. • Oral administration of _Joshanda_ (decoction) of Badiyan (Foeniculum vulgare Gaertn.) 10.5 gm. with _Gulqand_ _Asli_ 35gm in the morning [17].

• Oral administration of _Safoof_ (Powder) of following

Table 2: Ingredients of _Safoof_. • Oral administration of 3.5gm of _Habb-e-Khizran_ (Pills Khizran) (prepared with fallowing ingredients) (Table 3).

Table 3: Ingredients of _Habb-e-Khizran._ • Oral administration of 7-10.5gm _Habb-e-Wasili_ (Pills Wasili) prepared with fallowing ingredients (Table 4).

Table 4: Ingredients of _Habb-e-Wasili_. • Oral administration of _Safoof_ (Powder) of _Ustukhudus_ (_Lavandula stoechas_ Linn) in a dose of 1gm with 12gm Of _Itrifal Saghir_, followed by administration of _Joshanda_ (decoction) of _Gul-i-Khatmi_ (Flower of _Althae officinalis_ _Linn_.) 3gm., _Mawiz Munaqqa_ (_Vitis vinefera_ Linn.) 10 pices, _Tukhm-e-Kasni_ (seed of _Cichorium intybus_ Linn.) 6gm. Mixed with 12ml of honey and sprinkled with 6gm of _Asphol_ (_Plantago ovata Forsk_). • _Abzan_ (Sitz bath) with _Joshanda_ (decoction) of following drugs [18] (Table 5).

Table 5: Ingredients of _Joshanda_ with _Abzan_. • _Abzan_ (Sitz bath) with _Joshanda_ (decoction) of following drugs (Table 6).

Table 6: Ingredients of _Joshanda_ with _Abzan_. • _Abzan_ (Sitz bath) with _Joshanda_ (decoction) of following drugs (Table 7) in quantity of 24gm each.

Table 7: Ingredients of _Joshanda_ with _Abzan_.

• Natul (Irrigation) with Joshanda (decoction) of following drugs (Table 8).

[INLINE_TABLE:4:0]

Table 8: Ingredients of _Joshanda_ with _Natul_. • Application of paste of following drugs (Table 9) on the bladder area after mixing with juice of cabbage and _Roghan-i-Khasak_.

Table 9: Ingredients of paste. • Application of paste of _Shora Qalmi_ (Potassium nitrate) on the bladder area. • Application of _Roghan-i-Khasak_ at pubic region. • Application of _Roghan-i-Babuna_ at pubic region. • Application of _Roghan-i-Gul_ at pubic region. • Application of hot paste of _Rewand Chini_ (_Rheum emodi_ Wall.) mixed with Arq-i-Badyan at pubic area, testicles and around urethra.

Compound Unani Drugs

The compound formulations which have been given in Unani classical literature for the management of prostatomegaly are discussed below as in Table 10.

Table 10: Compound Formulation (Murakkab Adviya). _Ilaj-Bil-Tadbeer_ (Regimenal therapy) • Natul (Irrigation) • Urethral catheterization • _Abzan_ (Sitz bath) Dietary Recommendations (_Ilaj-Bil-Ghiza_) • _Aghziya Murattiba_ Dietary Restrictions • _Aghziya Hamiza_ • _Aghziya Ghaliza_ • _Aghziya Qabiza_

• _Aghziya Muwallid-i-Sawda_ • _Aghziya Muwa;;id-i-Balgham_ Investigation Required • USG (W/A). • Serum prostate-specific antigen (PSA). • Uroflowmetry.

Methodology

The databanks used to get information from journals and articles are Google, PubMed, Science Direct, Scopus and Google Scholar. For the search of primordial and current Unani classical literature author visited Library of Regional Research Institute of Unani Medicine (RRIUM), Srinagar, J & K, India and School of Unani Medical Education and Research Jamia Hamdard, New Delhi.

Conclusion

The morphological anatomy of the prostate gland has been established. They are the peripheral zone (PZ), transitional zone (TZ), central zone (CZ), the anterior fibro muscular area and the pre prostatic area. The contributions of zonal areas in a normal gland are PZ 70- 80%, TZ 10%, CZ 20%. In benign prostatic hyperplasia/hypertrophy/enlargement (BPH/BPE), only the transitional zone is affected and constitutes 100% of prostatomegaly. So it has been observed that these formulations when used clinically have marked effect in reducing the volume of the prostate by acting on the transitional zone. To overcome the misery of the prostatic symptoms and to maintain the proper sleep, the different regimenal therapies employed by Unani physician from time to time has in general gained the importance of Unani system of medicine for prostatomegaly.

References

1. Jeelani HG (1923) Makhzanul Jawahir (Tibbi Lugat),

Manager Tibbi Kutbkhana, Lahore, 607: 917-918.

2. Alqamri AMH (2010) Ghina Muna 1st (Edn), CCRUM,

New Delhi, 497: 309-310.

3. Ibne Sena (2010) Alqanoonfittib (Urdu translation by Ghulam Hasnain kantoori), Ejaz publishing House, New Delhi, 3: 1023.

4. Ibn Sina (1411) Al-Qanun-fil-Tibb, (Part II), Jamia

Hamdard, New Delhi, 3: 762-781.

5. Mohammad Azam Khan (1906) Iksir-i-Azam, Matab

Nami, Munshi Naval Kishor Lucknow, 3: 498-516.

6. Nafis B, Iwaz (1326) Sharah-al-Asbab-wa-al-Alamat,

Matab Nami, Munshi Naval Kishor Lucknow, 2: 193- 205.

7. Tho TD, Thanh NV, Thuc DV, Khanh Hy DT, Bien TK, et al. (2005) Assessment of therapeutic effect of softgel Crinum latifolium for benign prostate hypertrophy. Ministry of Health, Hanoi.

8. Qarabadeen Azam wa Akmal (2005) Urdu translation, CCRUM, New Delhi, 250-253.

9. Ali Ibn Abbas Majoosi (2010) Kamil-e-Sana`ah (Urdu

translation by Ghulam Hasnain Kantoori), Idara kitabulshifa, New Delhi, II: Maqalah 9th, 2: 528-529.

10. Ibn Qafful Masihi (2000) Kitab ul Umdah fil Jarahat,

CCRUM, New Delhi, I: 162.

11. Manoranjan Sahu, Ramesh Bhat, Kala Suhas Kulkarni

(2003) Clinical evaluation of Himplasia in benign prostate hyperplasia. Medicine update 1(11): 75-78.

12. Mark HE, Mark G (2007) Benign Prostate Hyperplasia

management in primary care screening and therapy. HSR&D evidence synthesis pilot program-BPH. US Department of veteran affairs Health services research and Development services.

13. Surveillance Epidemiology Age Adjusted Cancer

incidence in men in United States 1975-2005 “Surveillance Epidemiology and End Results” Program (SEER) Division of cancer control and population sciences. National Cancer Institute USA.

14. Osegbe DN (1997) Prostate cancer in Nigerians: facts and nonfacts. J Urol 157(4): 1340-1343.

15. Haas GP, Delongchamps N, Brawley OW, Wang CY,

Dela RG (2008) World Wide Epidemiology of Prostate cancer: perspective from autopsy studies. Can J Urology 15(1): 3866-3871.

16. Mohammad Azam Khan (2006) Rumuz-i- Azam,

CCRUM, New Delhi, II: 155-159.

17. Mohammad Azam Khan (1906) Iksir-i-Azam, Matab

Nami, Munshi Naval Kishor Lucknow, IV: 289-308.

18. Muhammad Bin Zakariya Razi (1308) Kitab-al-Hawi-

fil-Tibb, Daira Al-Maarif-Al-Usmaniya, Hyderabad, X: 153-188.

Ingredients of Joshanda.

Ingredients of Safoof.

Ingredients of Habb-e-Khizran.

Ingredients of Habb-e-Wasili.

Ingredients of Joshanda with Abzan.

Ingredients of Joshanda with Abzan.

Ingredients of Joshanda with Abzan.

Ingredients of paste.

Compound Formulation (Murakkab Adviya).

References

  1. Jeelani HG (1923) Makhzanul Jawahir (Tibbi Lugat), Manager Tibbi Kutbkhana, Lahore, 607: 917-918.
  2. Alqamri AMH (2010) Ghina Muna 1st (Edn), CCRUM, New Delhi, 497: 309-310.
  3. Ibne Sena (2010) Alqanoonfittib (Urdu translation by Ghulam Hasnain kantoori), Ejaz publishing House, New Delhi, 3: 1023.
  4. Ibn Sina (1411) Al-Qanun-fil-Tibb, (Part II), Jamia Hamdard, New Delhi, 3: 762-781.
  5. Mohammad Azam Khan (1906) Iksir-i-Azam, Matab Nami, Munshi Naval Kishor Lucknow, 3: 498-516.
  6. Nafis B, Iwaz (1326) Sharah-al-Asbab-wa-al-Alamat, Matab Nami, Munshi Naval Kishor Lucknow, 2: 193- 205.
  7. Tho TD, Thanh NV, Thuc DV, Khanh Hy DT, Bien TK, et al. (2005) Assessment of therapeutic effect of softgel Crinum latifolium for benign prostate hypertrophy. Ministry of Health, Hanoi.
  8. Qarabadeen Azam wa Akmal (2005) Urdu translation, CCRUM, New Delhi, 250-253.
  9. Ali Ibn Abbas Majoosi (2010) Kamil-e-Sana`ah (Urdu translation by Ghulam Hasnain Kantoori), Idara kitabulshifa, New Delhi, II: Maqalah 9th, 2: 528-529.
  10. Ibn Qafful Masihi (2000) Kitab ul Umdah fil Jarahat, CCRUM, New Delhi, I: 162.
  11. Manoranjan Sahu, Ramesh Bhat, Kala Suhas Kulkarni (2003) Clinical evaluation of Himplasia in benign prostate hyperplasia. Medicine update 1(11): 75-78.
  12. Mark HE, Mark G (2007) Benign Prostate Hyperplasia management in primary care screening and therapy. HSR&D evidence synthesis pilot program-BPH. US Department of veteran affairs Health services research and Development services.
  13. Surveillance Epidemiology Age Adjusted Cancer incidence in men in United States 1975-2005 “Surveillance Epidemiology and End Results” Program (SEER) Division of cancer control and population sciences. National Cancer Institute USA.
  14. Osegbe DN (1997) Prostate cancer in Nigerians: facts and nonfacts. J Urol 157(4): 1340-1343.
  15. Haas GP, Delongchamps N, Brawley OW, Wang CY, Dela RG (2008) World Wide Epidemiology of Prostate cancer: perspective from autopsy studies. Can J Urology 15(1): 3866-3871.
  16. Mohammad Azam Khan (2006) Rumuz-i- Azam, CCRUM, New Delhi, II: 155-159.
  17. Mohammad Azam Khan (1906) Iksir-i-Azam, Matab Nami, Munshi Naval Kishor Lucknow, IV: 289-308.
  18. Muhammad Bin Zakariya Razi (1308) Kitab-al-Hawi- fil-Tibb, Daira Al-Maarif-Al-Usmaniya, Hyderabad, X: 153-188.

PDF of this article

Related articles